Atlas Trials

Trastuzumab in Treating Patients With Recurrent Osteosarcoma

Clinical trial NCT00005033 · COMPLETED

Trial details

NCT number
NCT00005033
Sponsor
Memorial Sloan Kettering Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Sarcoma
Start date
1999-12-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.